ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET

BioPharma Credit.
91 announcements.
Time Date Ticker Company Announcement
16:00 23-12-2024 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
15:41 17-12-2024 BPCR BioPharma Credit
Director/PDMR Shareholding
16:00 05-12-2024 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
10:45 20-11-2024 BPCR BioPharma Credit
Holding(s) in Company
10:38 20-11-2024 BPCR BioPharma Credit
Holding(s) in Company
07:00 20-11-2024 BPCR BioPharma Credit
Director Declaration
17:39 14-11-2024 BPCR BioPharma Credit
Director Declaration
07:00 12-11-2024 BPCR BioPharma Credit
STATEMENT RE IMMUNOCORE HOLDINGS PLC
12:15 07-11-2024 BPCR BioPharma Credit
NEW INVESTMENT OF UP TO US$250 MILLION
12:16 04-11-2024 BPCR BioPharma Credit
Director/PDMR Shareholding
11:51 01-11-2024 BPCR BioPharma Credit
Total Voting Rights
07:00 01-11-2024 BPCR BioPharma Credit
UPDATE ON INVESTMENT
07:00 31-10-2024 BPCR BioPharma Credit
NEW INVESTMENT OF US$35 MILLION
16:00 21-10-2024 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
11:00 01-10-2024 BPCR BioPharma Credit
Total Voting Rights
16:00 27-09-2024 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
07:00 24-09-2024 BPCR BioPharma Credit
Half-year Report
07:00 19-09-2024 BPCR BioPharma Credit
Dividend Declaration
07:00 05-09-2024 BPCR BioPharma Credit
UPDATE RE COLLEGIUM PHARMACEUTICAL, INC.
10:56 02-09-2024 BPCR BioPharma Credit
Total Voting Rights
16:00 30-08-2024 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
10:28 16-08-2024 BPCR BioPharma Credit
Notice of Half Year Results
11:28 05-08-2024 BPCR BioPharma Credit
Director/PDMR Shareholding
14:51 01-08-2024 BPCR BioPharma Credit
Total Voting Rights
07:00 01-08-2024 BPCR BioPharma Credit
STATEMENT RE LUMIRADX
16:00 26-07-2024 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
07:00 22-07-2024 BPCR BioPharma Credit
UPDATE ON INVESTMENT
07:00 01-07-2024 BPCR BioPharma Credit
UPDATE ON INVESTMENT
16:00 21-06-2024 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
17:10 20-06-2024 BPCR BioPharma Credit
Dividend Declaration
15:09 12-06-2024 BPCR BioPharma Credit
Result of AGM
11:41 03-06-2024 BPCR BioPharma Credit
Total Voting Rights
08:11 28-05-2024 BPCR BioPharma Credit
UPDATE ON INVESTMENT
16:00 22-05-2024 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
11:40 13-05-2024 BPCR BioPharma Credit
Director/PDMR Shareholding
15:11 10-05-2024 BPCR BioPharma Credit
STATEMENT RE COHERUS BIOSCIENCES, INC.
15:52 08-05-2024 BPCR BioPharma Credit
Holding(s) in Company
12:18 02-05-2024 BPCR BioPharma Credit
NEW INVESTMENT OF UP TO US$400 MILLION
10:25 01-05-2024 BPCR BioPharma Credit
Total Voting Rights
07:00 24-04-2024 BPCR BioPharma Credit
NEW INVESTMENT OF UP TO US$100 MILLION
16:00 22-04-2024 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
16:48 27-03-2024 BPCR BioPharma Credit
Director/PDMR Shareholding
07:01 27-03-2024 BPCR BioPharma Credit
UPDATES TO THE DISCOUNT CONTROL MECHANISM
07:00 27-03-2024 BPCR BioPharma Credit
FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
11:35 25-03-2024 BPCR BioPharma Credit
Director/PDMR Shareholding
16:05 21-03-2024 BPCR BioPharma Credit
Dividend Declaration
16:35 15-03-2024 BPCR BioPharma Credit
UPDATE ON INVESTMENT
16:00 11-03-2024 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
15:10 01-03-2024 BPCR BioPharma Credit
Total Voting Rights
07:00 27-02-2024 BPCR BioPharma Credit
Notice of Full Year Results
07:00 13-02-2024 BPCR BioPharma Credit
STATEMENT RE IMMUNOGEN, INC.
07:00 08-02-2024 BPCR BioPharma Credit
Dividend Declaration
07:00 06-02-2024 BPCR BioPharma Credit
STATEMENT RE COHERUS BIOSCIENCES, INC.
10:39 01-02-2024 BPCR BioPharma Credit
Total Voting Rights
16:00 31-01-2024 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
12:35 22-01-2024 BPCR BioPharma Credit
Director/PDMR Shareholding
10:36 10-01-2024 BPCR BioPharma Credit
Transaction in Own Shares
07:00 02-01-2024 BPCR BioPharma Credit
UPDATE ON INVESTMENT
11:04 28-12-2023 BPCR BioPharma Credit
Result of General Meeting
16:00 21-12-2023 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
11:25 11-12-2023 BPCR BioPharma Credit
UPDATE ON INVESTMENT
07:00 01-12-2023 BPCR BioPharma Credit
STATEMENT RE IMMUNOGEN, INC.
07:00 29-11-2023 BPCR BioPharma Credit
DIVIDEND DECLARATION
07:00 22-11-2023 BPCR BioPharma Credit
NET ASSET VALUE(S)
07:01 22-11-2023 BPCR BioPharma Credit
UPDATE ON INVESTMENT
07:00 02-11-2023 BPCR BioPharma Credit
UPDATE ON INVESTMENT
07:00 01-11-2023 BPCR BioPharma Credit
UPDATE ON INVESTMENT
07:00 01-11-2023 BPCR BioPharma Credit
TRIGGER OF A CONTINUATION RESOLUTION
15:30 31-10-2023 BPCR BioPharma Credit
Director Declaration
07:00 24-10-2023 BPCR BioPharma Credit
UPDATE ON INVESTMENT
16:00 20-10-2023 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
07:00 12-10-2023 BPCR BioPharma Credit
UPDATE ON INVESTMENT
13:32 02-10-2023 BPCR BioPharma Credit
Director/PDMR Shareholding
07:00 27-09-2023 BPCR BioPharma Credit
Half-year Report
11:20 26-09-2023 BPCR BioPharma Credit
UPDATE ON INVESTMENT
16:00 22-09-2023 BPCR BioPharma Credit
Net Asset Value(s) and Monthly Factsheet
07:00 19-09-2023 BPCR BioPharma Credit
Update on Investment
07:00 31-08-2023 BPCR BioPharma Credit
Notice of Half Year Results
11:25 29-08-2023 BPCR BioPharma Credit
Update on Investment
07:00 10-08-2023 BPCR BioPharma Credit
Dividend Declaration
07:00 31-07-2023 BPCR BioPharma Credit
STATEMENT RE REATA PHARMACEUTICALS
11:30 21-07-2023 BPCR BioPharma Credit
UPDATE ON INVESTMENT
07:00 18-07-2023 BPCR BioPharma Credit
UPDATE ON INVESTMENT
13:34 03-07-2023 BPCR BioPharma Credit
Total Voting Rights
07:00 03-07-2023 BPCR BioPharma Credit
Update on Investment
07:00 08-06-2023 BPCR BioPharma Credit
UPDATE ON INVESTMENT
12:04 01-06-2023 BPCR BioPharma Credit
Total Voting Rights
15:08 30-05-2023 BPCR BioPharma Credit
Result of AGM
07:00 19-05-2023 BPCR BioPharma Credit
Update on Investment
15:40 16-05-2023 BPCR BioPharma Credit
Director/PDMR Shareholding
07:00 11-05-2023 BPCR BioPharma Credit
NEW INVESTMENT OF UP TO US$137.5 MILLION